Cover Image

Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer: secondary analysis of the geparsixto randomized clinical trial

Saved in:
Bibliographic Details
Main Authors: Hahnen, Eric Thomas (Author) , Schneeweiss, Andreas (Author)
Format: Article (Journal)
Language:English
Published: October 2017
In: JAMA oncology
Year: 2017, Volume: 3, Issue: 10, Pages: 1378-1385
ISSN:2374-2445
DOI:10.1001/jamaoncol.2017.1007
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1001/jamaoncol.2017.1007
Get full text
Author Notes:Eric Hahnen, PhD, Bianca Lederer, PhD, Jan Hauke, PhD, Sibylle Loibl, MD, Sandra Kröber, Andreas Schneeweiss, MD, Carsten Denkert, MD, Peter A. Fasching, MD, Jens U. Blohmer, MD, Christian Jackisch, MD, Stefan Paepke, MD, Bernd Gerber, MD, Sherko Kümmel, MD, Christian Schem, MD, Guido Neidhardt, MSc, Jens Huober, MD14, Kerstin Rhiem, MD, Serban Costa, MD, Janine Altmüller, MD, Claus Hanusch, MD, Holger Thiele, MD, Volkmar Müller, MD, Peter Nürnberg, PhD,,Thomas Karn, MD, Valentina Nekljudova, PhD, Michael Untch, MD, Gunter von Minckwitz, MD, Rita K. Schmutzler, MD

MARC

LEADER 00000caa a22000002c 4500
001 1575188554
003 DE-627
005 20230427042903.0
007 cr uuu---uuuuu
008 180516s2017 xx |||||o 00| ||eng c
024 7 |a 10.1001/jamaoncol.2017.1007  |2 doi 
035 |a (DE-627)1575188554 
035 |a (DE-576)505188554 
035 |a (DE-599)BSZ505188554 
035 |a (OCoLC)1341009700 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hahnen, Eric Thomas  |d 1968-  |e VerfasserIn  |0 (DE-588)121884368  |0 (DE-627)081597592  |0 (DE-576)292937016  |4 aut 
245 1 0 |a Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer  |b secondary analysis of the geparsixto randomized clinical trial  |c Eric Hahnen, PhD, Bianca Lederer, PhD, Jan Hauke, PhD, Sibylle Loibl, MD, Sandra Kröber, Andreas Schneeweiss, MD, Carsten Denkert, MD, Peter A. Fasching, MD, Jens U. Blohmer, MD, Christian Jackisch, MD, Stefan Paepke, MD, Bernd Gerber, MD, Sherko Kümmel, MD, Christian Schem, MD, Guido Neidhardt, MSc, Jens Huober, MD14, Kerstin Rhiem, MD, Serban Costa, MD, Janine Altmüller, MD, Claus Hanusch, MD, Holger Thiele, MD, Volkmar Müller, MD, Peter Nürnberg, PhD,,Thomas Karn, MD, Valentina Nekljudova, PhD, Michael Untch, MD, Gunter von Minckwitz, MD, Rita K. Schmutzler, MD 
264 1 |c October 2017 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.05.2018 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
773 0 8 |i Enthalten in  |t JAMA oncology  |d Chicago, Ill. : American Medical Association, 2015  |g 3(2017), 10, Seite 1378-1385  |h Online-Ressource  |w (DE-627)818494301  |w (DE-600)2810928-4  |w (DE-576)426501284  |x 2374-2445  |7 nnas  |a Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer secondary analysis of the geparsixto randomized clinical trial 
773 1 8 |g volume:3  |g year:2017  |g number:10  |g pages:1378-1385  |g extent:8  |a Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer secondary analysis of the geparsixto randomized clinical trial 
856 4 0 |u http://dx.doi.org/10.1001/jamaoncol.2017.1007  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180516 
993 |a Article 
994 |a 2017 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |e 910000PS109972554  |e 910400PS109972554  |k 0/910000/  |k 1/910000/910400/  |p 6 
999 |a KXP-PPN1575188554  |e 3009517742 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Hahnen, Eric Thomas","family":"Hahnen","role":"aut","given":"Eric Thomas"},{"role":"aut","given":"Andreas","display":"Schneeweiss, Andreas","family":"Schneeweiss"}],"relHost":[{"language":["eng"],"title":[{"title":"JAMA oncology","title_sort":"JAMA oncology"}],"note":["Gesehen am 12.10.2017"],"id":{"issn":["2374-2445"],"eki":["818494301"],"zdb":["2810928-4"]},"corporate":[{"display":"American Medical Association","role":"isb"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2015 -"],"recId":"818494301","physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"8","year":"2017","pages":"1378-1385","volume":"3","text":"3(2017), 10, Seite 1378-1385","issue":"10"},"disp":"Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer secondary analysis of the geparsixto randomized clinical trialJAMA oncology","origin":[{"dateIssuedDisp":"2015-","publisher":"American Medical Association","dateIssuedKey":"2015","publisherPlace":"Chicago, Ill."}]}],"recId":"1575188554","language":["eng"],"title":[{"title_sort":"Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer","subtitle":"secondary analysis of the geparsixto randomized clinical trial","title":"Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer"}],"note":["Gesehen am 16.05.2018"],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"October 2017"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"8 S."}],"id":{"doi":["10.1001/jamaoncol.2017.1007"],"eki":["1575188554"]},"name":{"displayForm":["Eric Hahnen, PhD, Bianca Lederer, PhD, Jan Hauke, PhD, Sibylle Loibl, MD, Sandra Kröber, Andreas Schneeweiss, MD, Carsten Denkert, MD, Peter A. Fasching, MD, Jens U. Blohmer, MD, Christian Jackisch, MD, Stefan Paepke, MD, Bernd Gerber, MD, Sherko Kümmel, MD, Christian Schem, MD, Guido Neidhardt, MSc, Jens Huober, MD14, Kerstin Rhiem, MD, Serban Costa, MD, Janine Altmüller, MD, Claus Hanusch, MD, Holger Thiele, MD, Volkmar Müller, MD, Peter Nürnberg, PhD,,Thomas Karn, MD, Valentina Nekljudova, PhD, Michael Untch, MD, Gunter von Minckwitz, MD, Rita K. Schmutzler, MD"]}} 
SRT |a HAHNENERICGERMLINEMU2017 

Similar Items